Description     Claims     Drawing  

WO0220737A   [0007] 
US20060003404A1   [0134] 
US62202990B   [0326] 

Cellular uptake mechanisms and potential therapeutic utility of peptidic cell delivery vectors: progress 2001-2006   [0006] 
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics   [0006] 
Cell cycle kinases as therapeutic targets for cancer   [0006] 
Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration   [0006] 
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis   [0006] 
Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase   [0006] 
Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide   [0006] 
Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor   [0006] 
Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor   [0006] 
In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes   [0006] 
Cell-.permeable NM23 blocks the maintenance and progression of established pulmonary metastasis   [0006] 
Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals   [0006] 
Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells   [0006] 
The effect of intracellular protein delivery on the anti-tumor activity of recombinant human endostatin   [0006] 
Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors   [0006] 
Inducible gene targeting in mice using the Cre/lox system   [0006] 
Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination   [0006] 
Inducible gene targeting in mice   [0006] 
Targeted oncogene activation by site-specific recombination in transgenic mice   [0006] 
A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination   [0006] 
CREating breakthroughs   [0006] 
Genomic targeting with an MBP-Cre fusion protein   [0006] 
Genomic targeting with purified Cre recombinase   [0006] 
Receptor/transporter-independent targeting of functional peptides across the plasma membrane.   [0006] 
Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration   [0006] 
Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase   [0006] 
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence   [0006] 
Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins   [0006] 
Solid-Phase Peptide Synthesis   [0124] 
Molecular Cloning: A Laboratory Manual   [0125]  [0128] 
Current Protocols in Molecular Biology   [0125] 
Gene   [0125] 
Nature   [0125] 
Current Protocols in Molecular Biology   [0128] 
Novagen, pET System manual   [0136] 
Protein Purification: Principles and Practice   [0141] 
Inhibition of Nuclear Translocation of Transcription Factor NF-kB by a Synthetic peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence   [0161] 
Epigenetic Regulation of Gene Structure and Function with a Cell-Permeable Cre Recombinase   [0161] 
Cell-Permeable NM23 Blocks the Maintenance and Progression of Established Pulmonary Metastasis   [0161] 
Antitumor Activity of Cell-Permeable p18INK4c With Enhanced Membrane and Tissue Penetration   [0161] 
Antitumor Activity of Cell-Permeable RUNX3 Protein in Gastric Cancer Cells   [0161] 
The Effect of Intracellular Protein Delivery on the Anti-Tumor Activity of Recombinant Human Endostatin   [0161] 
Partial Somatic to Stem Cell Transformations Induced By Cell-Permeable Reprogramming Factors   [0161] 
Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals   [0161]